Anbio Biotechnology(NNNN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NNNN Anbio Biotechnology

Not Yet Opened 04-20 16:00:00 EDT

26.98

-0.17

-0.63%

盘后26.98

+0.000.00%

16:18 EDT

High27.62	Low26.52	Vol21.84K
Open27.44	D1 Closing27.15	Amplitude4.03%
Mkt Cap3.88B	Tradable Cap1.07B	Total Shares143.89M
T/O589.44K	T/O Rate0.06%	Tradable Shares39.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NNNN","market":"US","secType":"STK","nameCN":"Anbio Biotechnology","latestPrice":26.98,"timestamp":1776715200000,"preClose":27.15,"halted":0,"volume":21841,"hourTrading":{"tag":"盘后","latestPrice":26.98,"preClose":26.98,"latestTime":"16:18 EDT","volume":23,"amount":631.14,"timestamp":1776716323524,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006261510128913376,"floatShares":39691200,"shares":143891200,"eps":0.146626,"marketStatus":"Not Yet Opened","change":-0.17,"latestTime":"04-20 16:00:00 EDT","open":27.44,"high":27.615,"low":26.52,"amount":589437.2681,"amplitude":0.040331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.146626,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776758400000},"marketStatusCode":0,"adr":0,"listingDate":1739941200000,"exchange":"NASDAQ","adjPreClose":27.15,"preHourTrading":{"tag":"盘前","latestPrice":28,"preClose":27.15,"latestTime":"08:58 EDT","volume":1,"amount":28,"timestamp":1776689938628,"change":0.85,"changeRate":0.031308,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":26.98,"preClose":26.98,"latestTime":"16:18 EDT","volume":23,"amount":631.14,"timestamp":1776716323524,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.655244},"requestUrl":"/m/hq/s/NNNN/tweets","defaultTab":"tweets","newsList":[{"id":"2626131438","title":"Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2626131438","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626131438?lang=en_us&edition=fundamental","pubTime":"2026-04-10 00:46","pubTimestamp":1775753160,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology reported strong 2025 results with sales of $8.65M. The company is diversifying away from COVID products.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/09/Close-up-View-To-Micromanipulation-With-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/09/Close-up-View-To-Micromanipulation-With-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/earnings/26/04/51737825/anbio-biotechnology-posts-solid-fy25-results-diversifies-portfolio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/04/51737825/anbio-biotechnology-posts-solid-fy25-results-diversifies-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["POCT","BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626975518","title":"Anbio Biotechnology CFO Suki Song files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626975518","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626975518?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:02","pubTimestamp":1775692956,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology filed Form 3 naming Suki Song as CFO in an initial beneficial ownership report dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL3Nhv6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626975512","title":"Anbio Biotechnology director Nancy Hartzler files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626975512","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626975512?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:02","pubTimestamp":1775692932,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology director Nancy Hartzler filed an initial statement of beneficial ownership dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL8XBv6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626197551","title":"Anbio Biotechnology CEO Michael Lau files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626197551","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626197551?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:01","pubTimestamp":1775692868,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology filed an initial beneficial ownership statement naming Michael Lau as CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL1h5Y4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626753749","title":"Anbio Biotechnology CBO Chris Tian files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626753749","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626753749?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:00","pubTimestamp":1775692839,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology disclosed a Form 3 filing naming Chris Tian as chief business officer, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2Th2Jg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626753789","title":"Anbio Biotechnology director Cany Xu files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626753789","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626753789?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:00","pubTimestamp":1775692816,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology filed an initial Form 3 listing Cany Xu as a director, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL5V1VLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625965741","title":"Anbio Biotechnology FY25 net income more than doubled to $6.4 million; revenue rises 5.64% to $8.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2625965741","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625965741?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:17","pubTimestamp":1775593066,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology posted fiscal 2025 net income of $6.4 million, up 169.9%.Operating income climbed to $5.8 million from $2 million.Gross margin widened 15.3 percentage points to 87.2%.Results reflected continued orders from key customers, with higher sales of conventional IVD, animal-related, and customized products as demand for COVID-19-related products normalized.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLbhvJd6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620385403","title":"Anbio Biotechnology CEO to Join KeyBanc Capital Markets Virtual Healthcare Forum Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2620385403","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620385403?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:31","pubTimestamp":1773779462,"startTime":"0","endTime":"0","summary":"Anbio will participate in the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026. The company’s CEO is scheduled to take part in a fireside chat during the event.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9g1bp9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","LU0496365809.HKD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","LU0211326839.USD","SG9999014021.USD","IE00BN0W2W23.USD","KEY","BK4211","LU0128525689.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4112","LU2095319765.USD","BK4207","IE00BGHQF748.EUR","NNNN","BK4589","SG9999014005.SGD","LU0976567544.SGD","LU0314104364.USD","NDAQ","LU2210149790.SGD","LU0052756011.USD","BK4585","LU1267930227.SGD","LU0310800965.SGD","LU0211326755.USD","IE00BN0W2V16.EUR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612496283","title":"Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612496283","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612496283?lang=en_us&edition=fundamental","pubTime":"2026-02-18 06:54","pubTimestamp":1771368856,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology Class A ( ($NNNN) ) has issued an announcement. On February 11, 2026, Anbio Biotechnology’s board and audit committee dismissed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-replaces-auditor-to-safeguard-2025-reporting-timeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-replaces-auditor-to-safeguard-2025-reporting-timeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608980620","title":"Anbio Biotechnology rises 20.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608980620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608980620?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:05","pubTimestamp":1770138327,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology (NNNN) is up 20.0%, or $4.94 to $29.60. Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-rises-20-0-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-rises-20-0-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608387894","title":"Anbio Biotechnology trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2608387894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608387894?lang=en_us&edition=fundamental","pubTime":"2026-02-03 02:35","pubTimestamp":1770057340,"startTime":"0","endTime":"0","summary":"13:28 EST Anbio Biotechnology (NNNN) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-6?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-6?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608891221","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:28 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608891221","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608891221?lang=en_us&edition=fundamental","pubTime":"2026-02-03 02:28","pubTimestamp":1770056922,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:28 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nAQN2LKDVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607059002","title":"Small U.S. Stocks Close Mixed As Anbio Biotechnology Leads, Richtech Robotics Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2607059002","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607059002?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:21","pubTimestamp":1769721660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Thursday, as the Russell 2000 Index closed flat, and the S&P Small Cap 600 Index was up 0.6%.Among companies with a market value of $1 billion to $6.7 billion, Anbio Biotechnology was the best performer during the session, surging 33%, followed by Viavi Solutions Inc., which jumped 17%. Liberty Energy Inc. shares surged 16%, Merchants Bancorp jumped 16%, and shares of ManpowerGroup jumped 15%.Richtech Robotics Inc. Cl B was the biggest laggard, dropping 21%, followed by shares of Critical Metals Corp., which dropped 18%. Shares of LendingClub Corp. dropped 16%, Vizsla Silver Corp. shares tumbled 15%, and United States Antimony Corp. tumbled 15%.Major U.S. stock indexes ended Thursday mixed with the Nasdaq Composite Index dropping 0.7%. Meanwhile, the S&P 500 Index dropped 0.1%, and the Dow Jones Industrial Average added 0.1%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","NNNN","BK4139","BK4161"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2607553860","title":"Anbio Biotechnology trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2607553860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607553860?lang=en_us&edition=fundamental","pubTime":"2026-01-30 03:55","pubTimestamp":1769716544,"startTime":"0","endTime":"0","summary":"14:51 EST Anbio Biotechnology (NNNN) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607053762","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:51 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2607053762","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607053762?lang=en_us&edition=fundamental","pubTime":"2026-01-30 03:51","pubTimestamp":1769716273,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:51 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nAQN2LJWNK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606226294","title":"U.S. Small Caps End Mixed As Northern Dynasty Minerals Leads, Anbio Biotechnology Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226294?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:21","pubTimestamp":1769462460,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Monday, as the Russell 2000 Index declined 0.4%, while the S&P Small Cap 600 Index was unchanged.Among companies with a market value of $1 billion to $6.7 billion, Anbio Biotechnology was the biggest laggard during the session, dropping 25%, followed by shares of Ramaco Resources Inc. Cl A, which dropped 20%. Shares of TMC the metals company Inc. dropped 18%, Biglari Holdings Inc. Cl A shares tumbled 15%, and Terrestrial Energy Inc. tumbled 15%.Northern Dynasty Minerals Ltd. was the best performer, surging 13%, followed by Pattern Group Inc., which jumped 13%. DigitalOcean Holdings Inc. shares surged 9.9%, Iovance Biotherapeutics Inc. surged 9.5%, and shares of Nexa Resources S.A. surged 9.0%.Major stock indexes in the U.S. moved upward Monday with the Nasdaq Composite Index rising 0.4%. Meanwhile, the S&P 500 Index gained 0.5%, and the Dow Jones Industrial Average added 0.6%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4168","NNNN","NAK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606856217","title":"Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2606856217","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606856217?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:57","pubTimestamp":1769428644,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology Class A ( ($NNNN) ) has provided an update. Effective January 21, 2026, Anbio Biotechnology appointed Michael Zhang, a finance ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-strengthens-board-oversight-with-appointment-of-michael-zhang-as-audit-committee-chair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-strengthens-board-oversight-with-appointment-of-michael-zhang-as-audit-committee-chair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603995884","title":"S&P 500 Futures Up In Premarket Trading; QXO, Mosaic Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2603995884","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603995884?lang=en_us&edition=fundamental","pubTime":"2026-01-16 20:31","pubTimestamp":1768566660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, AST SpaceMobile Inc.  was up 6.8% in pre-market trading, and Sandisk Corp.  was up 5.3%.Micron Technology Inc. , Anbio Biotechnology , and Seagate Technology Holdings PLC  were all posting gains of at least 4%. In early trading, QXO Inc.  and Mosaic Co.  had posted declines, falling 8.0% and 6.5%, respectively.Meanwhile S&P 500 futures were up 0.19%, with futures for the Dow Jones Industrial Average rising 0.03%. The Cboe Volatility Index futures were down 2.98%.In commodities news, Brent crude oil futures were up 1.47%, and gold futures were down 0.18%. Bitcoin climbed 0.32% to $95,499.In the previous regular trading session, the S&P 500 and the Dow were up 0.26% and 0.60%, respectively. Stocks in Asia were down overnight, with Japan's NIKKEI 225 Index down 0.32% and China's Shanghai Composite Index falling 0.26%.In afternoon trading, stock","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPMO","VTI","BMAY","SPLV","GPIX","SPYV","NNNN","HIBL","BK4543","LU0203347892.USD","LU2458330169.SGD","IE00B19Z9P08.USD","QXO","LU0345781412.USD","LU1323610961.USD","BK4588",".SPX","SSO","ESmain","IE00B19Z3B42.SGD","SH","SDS","SPXS","BK4550","UPRO","OEF","VOOV","BK4605","SPY","IE00B7SZLL34.SGD","BK4579","IE0009354923.USD","MOS","SPXU","MESmain","XDTE","SPDN","SPYM","IVOO","SPXL","BK4532","LU1316542783.SGD","IVW","VOO","IVV","OEX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2600033863","title":"Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?","url":"https://stock-news.laohu8.com/highlight/detail?id=2600033863","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600033863?lang=en_us&edition=fundamental","pubTime":"2026-01-01 19:26","pubTimestamp":1767266779,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology's (NASDAQ:NNNN) stock is up by a considerable 18% over the past three months. But the company's key...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nnnn/anbio-biotechnology/news/anbio-biotechnology-nasdaqnnnn-stock-is-going-strong-but-fun","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nnnn/anbio-biotechnology/news/anbio-biotechnology-nasdaqnnnn-stock-is-going-strong-but-fun","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SQQQ","PSQ","TQQQ",".IXIC","MNQmain","USJW.SI","NVIW.SI","NQmain","BK4139","QID","USAW.SI","QLD","TSYW.SI","NNNN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2588302468","title":"U.S. Small Caps Close Up; Anbio Biotechnology Top Leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2588302468","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588302468?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:20","pubTimestamp":1764796800,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies gained Wednesday, as the Russell 2000 Index gained 1.9%, and the S&P Small Cap 600 Index was up 1.5%.Among companies with a market value of $1 billion to $6.7 billion, Anbio Biotechnology was the best performer during the session, surging 25%, followed by Pharvaris N.V., which jumped 22%. American Eagle Outfitters Inc. shares surged 15%, Beam Therapeutics Inc. surged 14%, and shares of Fortrea Holdings Inc. surged 14%.TryHard Holdings Ltd. was the biggest laggard, dropping 26%, followed by shares of Omada Health Inc., which dropped 13%. Shares of Falcon's Beyond Global Inc. dropped 11%, Acadia Healthcare Co. Inc. shares plunged 11%, and BillionToOne Inc. plunged 11%.Major U.S. stock indexes closed up Wednesday as the Nasdaq Composite Index gained 0.2%. Meanwhile, the S&P 500 Index gained 0.3%, and the Dow Jones Industrial Average increased 0.9%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anbio.com","stockEarnings":[{"period":"1week","weight":-0.0547},{"period":"1month","weight":0.1461},{"period":"3month","weight":-0.1243},{"period":"6month","weight":-0.0298},{"period":"1year","weight":3.0817},{"period":"ytd","weight":-0.1028}],"compareEarnings":[{"period":"1week","weight":0.033},{"period":"1month","weight":0.0927},{"period":"3month","weight":0.046},{"period":"6month","weight":0.0613},{"period":"1year","weight":0.3463},{"period":"ytd","weight":0.0393}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. IVD products are designed to detect a wide range of biomarkers associated with critical medical domains. Its research and development activities for all IVD products: Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer. Its product AF-1200 Fluorescence Immunoassay Analyzer, AF-100 Fluorescence Immunoassay Analyzer, AF-100S Fluorescence Immunoassay Analyzer, AF-100C Fluorescence Immunoassay Analyzer.","exchange":"NASDAQ","name":"Anbio Biotechnology","nameEN":"Anbio Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anbio Biotechnology(NNNN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Anbio Biotechnology(NNNN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Anbio Biotechnology,NNNN,Anbio Biotechnology股票,Anbio Biotechnology股票老虎,Anbio Biotechnology股票老虎国际,Anbio Biotechnology行情,Anbio Biotechnology股票行情,Anbio Biotechnology股价,Anbio Biotechnology股市,Anbio Biotechnology股票价格,Anbio Biotechnology股票交易,Anbio Biotechnology股票购买,Anbio Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anbio Biotechnology(NNNN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Anbio Biotechnology(NNNN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}